U.S. markets close in 1 hour 31 minutes
  • S&P 500

    3,836.45
    -33.84 (-0.87%)
     
  • Dow 30

    31,422.74
    +31.22 (+0.10%)
     
  • Nasdaq

    13,027.91
    -330.88 (-2.48%)
     
  • Russell 2000

    2,222.92
    -8.59 (-0.39%)
     
  • Crude Oil

    61.35
    +1.60 (+2.68%)
     
  • Gold

    1,714.30
    -19.30 (-1.11%)
     
  • Silver

    26.27
    -0.61 (-2.27%)
     
  • EUR/USD

    1.2071
    -0.0016 (-0.13%)
     
  • 10-Yr Bond

    1.4640
    +0.0490 (+3.46%)
     
  • GBP/USD

    1.3959
    +0.0003 (+0.02%)
     
  • USD/JPY

    106.9870
    +0.2770 (+0.26%)
     
  • BTC-USD

    50,495.65
    +2,613.05 (+5.46%)
     
  • CMC Crypto 200

    1,010.93
    +22.83 (+2.31%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Seagen to Present at the J.P. Morgan Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Seagen Inc. (Nasdaq: SGEN) today announced that management will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on Monday, January 11, 2021 at 2:00 p.m. Eastern Time. The presentation will be webcast live and available for replay from Seagen’s website at www.seagen.com in the Investors section.

About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201216005222/en/

Contacts

Peggy Pinkston
(425) 527-4160
ppinkston@seagen.com